Congenital erythrocytosis and polycythemia vera in childhood and adolescence

Klinische Padiatrie

Volumn 216, Issue 3, 2004, Pages 157-162

  Cario, H ^a   Schwarz, K ^b,c   Debatin, K M ^a   Kohne, E ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Institute for Clinical Transfusion Medicine and Immunogenetics Ulm   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Congenital erythrocytosis; Observational trial; Polycythaemia; Polycythemia vera; Polyglobuly

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANAGRELIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN; HYDROXYUREA; PHOSPHORUS 32; THEOPHYLLINE; VON HIPPEL LINDAU PROTEIN;

ADOLESCENT; BLEEDING; CHILD; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; DISEASE CLASSIFICATION; ERYTHROCYTOSIS; HEMOGLOBINOPATHY; HUMAN; LABORATORY TEST; LEUKEMIA; MEDICAL CARE; MOLECULAR BIOLOGY; PHLEBOTOMY; POLYCYTHEMIA VERA; REVIEW; SIDE EFFECT;

2,3-DIPHOSPHOGLYCERATE; ADOLESCENT; ADULT; CHILD; CHROMOSOME ABERRATIONS; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DNA MUTATIONAL ANALYSIS; GENES, DOMINANT; HEMOGLOBINOPATHIES; HUMANS; MULTICENTER STUDIES; PATIENT CARE TEAM; POLYCYTHEMIA; POLYCYTHEMIA VERA; RECEPTORS, ERYTHROPOIETIN; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 2942737390     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822628     Document Type: Review

References (62)

1. Ang SO, Chen H, Gordeuk VR, Sergueeva AI, Polyakova LA, Miasnikova GY et al. Endemic polycythemia in Russia: mutation in the VHL gene. Blood Cells Mol Dis 2002; 28: 57-62
2. Ang SO, Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 2002; 32: 614-621
3. Arcasoy MO, Degar BA, Harris KW, Forget BG. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. Blood 1997; 89: 4628-4635
4. Arcasoy MO, Karayal AF, Segal HM, Sinning JG, Forget BG. A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis. Blood 2002; 99: 3066-3069
5. Bakris GL, Sauter ER, Hussey JL, Fisher JW, Gaber AO, Winsett R. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med 1990; 323: 86-90
6. Banerjee D, Rodriguez M, Nag M, Adamson JW. Exposure of endotheIial cells to recombinant human erythropoietin induces nitric oxide synthase activity. Kidney Int 2000; 57: 1895-1904
7. Bilgrami S, Greenberg BR. Polycythemia rubra vera. Semin Oncol 1995; 22: 307-326
8. Carlo H, Pahl HL, Schwarz K, Galm C, Hoffmann M, Burdelski M et al. Familial polycythemia vera with Budd-Chiari syndrome in childhood. Br J Haematol 2003; 123: 346-352
9. Cario H, Schwarz K, Debatin K-M, Kohne E. Kongenitale Erythrozytosen und Polycythaemia vera im Kindes- und Jugendalter. Monatsschr Kinderheilkd 2003; 151: 1113
10. Cartier P, Labie D, Leroux JP, Najman A, Demaugre F. [Familial diphosphoglycerate mutase deficiency: hematological and biochemical study]. Nouv Rev Fr Hematol 1972; 12: 269-287
11. Cazzola M, Guarnone R, Cerani P, Rovati A, Ascari E. Congenital erythropoietin-dependent erythrocytosis responsive to theophylline treatment. Blood 1998; 91: 360-361
12. Charache S, Weatherall DJ, Clegg JB. Polycythemia associated with a hemoglobinopathy. J Clin Invest 1966; 45: 813-822
13. Dallman PR, Siimes MA. Percentile curves for hemoglobin and red cell volume in infancy and childhood. J Pediatr 1979; 94: 26-31
14. Danish EH, Rasch CA, Harris JW. Polycythemia vera in childhood: case report and review of the literature. Am J Hematol 1980; 9: 421-428
15. de la Chapelle A, Traskelin AL, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci U S A 1993; 90: 4495-4499
16. Frezzato M, Ruggeri M, Castaman G, Rodeghiero F. Polycythemia vera and essential thrombocythemia in young patients. Haematologica 1993; 78 (Suppl 2): 11-17
17. Furukawa T, Narita M, Sakaue M, Otsuka T, Kuroha T, Masuko M et al. Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor. Br J Haematol 1997; 99: 222-227
18. Ghaffari S, Huang LJ, Zhang J, Lodish HF. Erythropoietin receptor signaling processes. In: Molineux G, Foote MA, Elliott SG (eds). Erythropoietins and Erythropoiesis. Birkhäuser, Basel, Boston, Berlin 2003; 65-86
19. Gilbert HS. Current management in polycythemia vera. Semin Hematol 2001; 38 (Suppl 2): 25-28
20. Gordeuk VR, Sergueeva AI, Miasnikova GY, Okhotin DJ, Prchal JT, Polyakova LA. High mortality due to thrombosis and cerebral hemorrhage in Chuvash Polycythemia. Blood 2001; 98: 224
21. Halbertsma T. Polycythemia in childhood with report of a case in a boy, six years old, with tower head. Am J Dis Child 1933; 1356-1367
22. Heilmann E, Klein CE, Beck JD. Primary polycythaemia in childhood and adolescence. Folia Haematol Int Mag Blutforsch 1983; 110: 935-941
23. Klinger JR, Petit RD, Curtin LA, Warburton RR, Wrenn DS, Steinhelper ME et al. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol 1993; 75: 198-205
24. Klingler KW, Lengfelder E, Kohne E, Arnold H. [Familial polyglobulism - a rare differential diagnosis of polycythemia vera]. Med Klin 1988; 83: 363-366
25. Kralovics R, Indrak K, Stopka T, Berman BW, Prchal JF, Prchal JT. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. Blood 1997; 90: 2057-2061
26. Kralovics R, Sokol L, Prchal JT. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. J Clin Invest 1998; 102: 124-129
27. Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 2004; 350: 114-124
28. Lengfelder E, Hehlmann R. [Polycythemia vera: current status of therapy]. Dtsch Med Wochenschr 2000; 125: 1243-1247
29. Lubin BH. Reference values in infancy and childhood. In: Nathan DG, Oski FA. Hematology of infancy and childhood. WB Saunders, Philadelphia 1993
30. Marshall JM. The Joan Mott Prize Lecture. The integrated response to hypoxia: from circulation to cells. Exp Physiol 1999; 84: 449-470
31. Ok E, Akcicek F, Toz H, Kursat S, Tobu M, Basci A et al. Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation. Transplantation 1995; 59: 1623-1626
32. Osgood EE. Polycythemia vera: Age relationship and survival. Blood 1965; 26: 243-256
33. Pastore YD, Jelinek J, Ang S, Guan Y, Liu E, Jedlickova K et al. Mutations in the VHL gene in sporadic apparently congenital polycythemia. Blood 2003; 101: 1591-1595
34. Pearson TC. Rheology of the absolute polycythaemias. Baillieres Clin Haematol 1987; 1: 637-664
35. Pearson TC. Apparent polycythaemia. Blood Rev 1991; 5: 205-213
36. Pearson TC, Messinezy M, Westwood N, Green AR, Bench AJ, Green AR et al. Polycythemia Vera Updated: Diagnosis, Pathobiology, and Treatment. Hematology 2000; 51-68
37. Percy MJ, McMullin MF, Jowitt SN, Potter M, Treacy M, Watson WH et al. Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood 2003; 102: 1097-1099
38. Percy MJ, McMullin MF, Roques AW, Westwood NB, Acharya J, Hughes AE et al. Erythrocytosis due to a mutation in the erythropoietin receptor gene. Br J Haematol 1998; 100: 407-410
39. Perea G, Remacha A, Besses C, Jimenez M, Florensa L, Cervantes F. Is polycythemia vera a serious disease in young adults? Haematologica 2001; 86: 543-544
40. Petitt RM, Silverstein MN, Petrone ME. Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders. Semin Hematol 1997; 34: 51-54
41. Pierre R, Imbert M, Thiele J, Vardiman JW, Brunning RD, Flandrin G. Polycythaemia vera. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumors. Pathology and Genetics. Tumors of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001; 32-34
42. Pollari G, Antonini V, Izzo A, Moreschini G, Serraino M, Tonelli V et al. The role of erythrocytapheresis in secondary erythrocytosis therapy. Clin Hemorheol Microcirc 1999; 21: 353-355
43. Prchal JT. Pathogenetic Mechanisms of Polycythemia Vera and Congenital Polycythemic Disorders. Semin Hematol 2001; 36 (Suppl 2): 10-20
44. Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C, Wagner K et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A 2000; 97: 11609-11613
45. Sagripanti A, Ferretti A, Nicolini A, Carpi A. Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders. Biomed Pharmacother 1996; 50: 376-382
46. Sandler A, Rivlin L, Filler R, Freedman M, Ky AJ. Polycythemia secondary to focal nodular hyperplasia. J Pediatr Surg 1997; 32: 1386-1387
47. Sergeyeva A, Gordeuk VR, Tokarev YN, Sokol L, Prchal JF, Prchal JT. Congenital polycythemia in Chuvashia. Blood 1997; 89: 2148-2154
48. Shibata J, Hasegawa J, Siemens HJ, Wolber E, Dibbelt L, Li D et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood 2003; 101: 4416-4422
49. Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 1995; 86: 15-22
50. Spivak JL. The optimal management of polycythemia vera. Brit J Haematol 2002; 116: 243-254
51. Tefferi A, Solberg LA, Silverstein MN. A clinical update in polycythemia vera and essential thrombocythemia. Am J Med 2000; 109: 141-149
52. Thomas DJ, du Boulay GH, Marshall J, Pearson TC, Ross Russell RW, Symon L et al. Cerebral blood-flow in polycythaemia. Lancet 1977; 2: 161-163
53. Thomas DJ, Marshall J, Russell RW, Wetherley-Mein G, du Boulay GH, Pearson TC et al. Effect of haematocrit on cerebral blood-flow in man. Lancet 1977; 2: 941-943
54. Turker M, Ozer EA, Oniz H, Atabay B, Yaprak I. Polycythemia vera in a 12-year-old girl: a case report. Ped Hematol Oncol 2002; 19: 263-266
55. Wajcman H, Galacteros F. Abnormal hemoglobins with high oxygen affinity and erythrocytosis. Hematol Cell Ther 1996; 38: 305-312
56. Watowich SS, Xie X, Klingmuller U, Kere J, Lindlof M, Berglund S et al. Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state. Blood 1999; 94: 2530-2532
57. Wick H. Polycythaemia vera mit neurologischen Komplikationen bei einem 12-jährigen Kind. Schweiz Med Wschr 1969; 99: 186-189
58. Wiesener MS, Seyfarth M, Warnecke C, Jurgensen JS, Rosenberger C, Morgan NV et al. Paraneoplastic erythrocytosis associated with an inactivating point mutation of the von Hippel-Lindau gene in a renal cell carcinoma. Blood 2002; 99: 3562-3565
59. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999; 103: 23-29
60. Yoshida M, Koshiyama M, Fujii H, Konishi M. Erythrocytosis and a fibroid. Lancet 1999; 354: 216
61. Zurcher C, Loos JA, Prins HK. Hereditary high ATP content of human erythrocytes. Folia Haematol Int Mag Klin Morphol Blutforsch 1965; 83: 366-376
62. Zarkovic M, Kwaan HC. Correction of hyperviscosity by apheresis. Semin Thromb Hemost 2003; 29: 535-542